Transcript

RGC efforts and expertise

Identifying Genetic Targets
>50 protectives variants
~30 drug targets advanced into pipeline

Predicting Disease Risk
Polygenic risk scores for Coronary Artery Disease, COVID-19, psychiatric disorders

Supporting Clinical Programs
Itepekimab for COPD
ODYSSEY trials design (Acute Coronary Syndrome)

Back
to top